Developing Enzymes In-house Ensures Savings and Control
As part of our comprehensive biotransformation offerings, we’ve developed significant expertise in fermentation to make biocatalysts for APIs or intermediates. Additionally we are developing our capabilities to manufacture enzyme therapeutics, initially for oral dosage forms, in the future for injectables.
Our experts can investigate the replacement of an expensive commercial enzyme in a technical package with an inhouse enzyme. This saves cost, reduces dependence on an external supplier, and allows full control of enzyme production/supply as needed for the project, on demand.
Diverse, large proprietary enzyme library available in-house for screening
Replacing chemical process with superior enzyme technology to reduce cost compared to precious metal catalysts
More environmentally friendly option than using precious metal catalysts
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
